아기오스제약(주)
US ˙ NasdaqGS ˙ US00847X1046

SecurityAGIO / Agios Pharmaceuticals, Inc.
InstitutionJefferies Group LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Jefferies Group LLC ownership in AGIO / Agios Pharmaceuticals, Inc.

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Agios Pharmaceuticals, Inc. (US:AGIO) valued at $0 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 17,010 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (AGIO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AGIO / Agios Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 0 -17,010 -100.00 0 -100.00
2022-11-14 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -17,010 0
2023-09-21 2022-06-30 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 17,010 3,418 25.15 377 -4.56 0.0031
2022-08-15 2022-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 17,010 3,418 377 0.0029
2023-09-21 2022-03-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 13,592 13,592 396 0.0025
2022-05-16 2022-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 13,592 13,592 396 0.0023
2023-09-21 2021-09-30 13F/A-2 AGIOS PHARMACEUTICALS COM 00847X104 0 -5,383 -100.00 0 -100.00
2021-12-17 2021-09-30 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 0 -5,383 0
2021-11-15 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -5,383 0
2023-09-21 2021-06-30 13F/A-2 AGIOS PHARMACEUTICALS COM 00847X104 5,383 5,383 297 0.0019
2021-08-20 2021-06-30 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 5,383 5,383 297 0.0018
2021-08-16 2021-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 5,383 5,383 297 0.0018
2023-09-21 2021-03-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 0 -8,132 -100.00 0 -100.00
2021-05-14 2021-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -8,132 0
2023-09-21 2020-12-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 8,132 -2,746 -25.24 352 -7.61 0.0028
2021-02-16 2020-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 8,132 -2,746 352 0.0032
2020-11-13 2020-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 10,878 10,878 33.77 381 8.24 0.0042
2020-11-02 2020-06-30 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 0 -40,000 -100.00 0 -100.00
2020-05-15 2020-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 40,000 20,507 105.20 1,419 52.42 0.0176
2020-02-13 2019-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 19,493 -34,535 -63.92 931 -46.83 0.0072
2019-11-13 2019-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 54,028 54,028 177.17 1,751 88.08 0.0136
2017-05-15 2017-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -500 -100.00 0 -100.00
2017-02-14 2016-12-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 500 500 0.00 21 0.0001
2017-02-14 2016-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 500 21
2016-08-12 2016-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -11,623 -100.00 0 -100.00
2016-05-11 2016-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 11,623 -15,031 -56.39 472 -72.72 0.0027
2016-02-12 2015-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 26,654 26,654 129.32 1,730 266.53 0.0098
2015-11-13 2015-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -8,600 -100.00 0 -100.00
2015-08-18 2015-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 8,600 8,600 956 0.0049
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-03-31 13F/A AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F AGIOS PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2023-09-21 2021-12-31 13F/A AGIOS PHARMACEUTICALS COM Call 25,400 835 n/a n/a n/a
2022-02-14 2021-12-31 13F AGIOS PHARMACEUTICALS COM Call 25,400 835 n/a n/a n/a
2020-11-02 2020-06-30 13F/A AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F AGIOS PHARMACEUTICALS COM Call 23,700 841 n/a n/a n/a
2017-05-15 2017-03-31 13F AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F/A AGIOS PHARMACEUTICALS COM Call 7,300 305 n/a n/a n/a
2017-02-14 2016-12-31 13F AGIOS PHARMACEUTICALS COM Call 7,300 305 n/a n/a n/a
2016-11-14 2016-09-30 13F AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-12 2016-06-30 13F AGIOS PHARMACEUTICALS COM Call 57,800 18.20 2,422 22.02 n/a n/a n/a
2016-05-11 2016-03-31 13F AGIOS PHARMACEUTICALS COM Call 48,900 17.55 1,985 -26.51 n/a n/a n/a
2016-02-12 2015-12-31 13F AGIOS PHARMACEUTICALS COM Call 41,600 -21.06 2,701 -27.39 n/a n/a n/a
2015-11-13 2015-09-30 13F AGIOS PHARMACEUTICALS COM Call 52,700 26.68 3,720 37.73 n/a n/a n/a
2015-05-18 2015-03-31 13F AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F AGIOS PHARMACEUTICALS COM Call 6,400 717 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A AGIOS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F AGIOS PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2023-09-21 2022-06-30 13F/A AGIOS PHARMACEUTICALS COM Put 17,000 0.00 377 -23.89 n/a n/a n/a
2022-08-15 2022-06-30 13F AGIOS PHARMACEUTICALS COM Put 17,000 377 n/a n/a n/a
2023-09-21 2022-03-31 13F/A AGIOS PHARMACEUTICALS COM Put 17,000 0.00 495 -11.47 n/a n/a n/a
2022-05-16 2022-03-31 13F AGIOS PHARMACEUTICALS COM Put 17,000 495 n/a n/a n/a
2023-09-21 2021-12-31 13F/A AGIOS PHARMACEUTICALS COM Put 17,000 559 n/a n/a n/a
2022-02-14 2021-12-31 13F AGIOS PHARMACEUTICALS COM Put 17,000 559 n/a n/a n/a
2021-12-17 2021-09-30 13F/A AGIOS PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2023-09-21 2021-09-30 13F/A AGIOS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F AGIOS PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2021-08-20 2021-06-30 13F/A AGIOS PHARMACEUTICALS COM Put 10,300 568 n/a n/a n/a
2023-09-21 2021-06-30 13F/A AGIOS PHARMACEUTICALS COM Put 10,300 568 n/a n/a n/a
2021-08-16 2021-06-30 13F AGIOS PHARMACEUTICALS COM Put 1,030,000 568 n/a n/a n/a
2023-09-21 2021-03-31 13F/A AGIOS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-14 2021-03-31 13F AGIOS PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2023-09-21 2020-12-31 13F/A AGIOS PHARMACEUTICALS COM Put 70,000 250.00 3,033 333.29 n/a n/a n/a
2021-02-16 2020-12-31 13F AGIOS PHARMACEUTICALS COM Put 70,000 3,033 n/a n/a n/a
2020-11-13 2020-09-30 13F AGIOS PHARMACEUTICALS COM Put 20,000 -71.43 700 -76.92 n/a n/a n/a
2020-05-15 2020-03-31 13F AGIOS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-13 2019-12-31 13F AGIOS PHARMACEUTICALS COM Put 30,000 -53.85 1,433 -31.96 n/a n/a n/a
2019-11-13 2019-09-30 13F AGIOS PHARMACEUTICALS COM Put 65,000 2,106 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.